Actuate Therapeutics (NASDAQ: ACTU) has announced positive Phase 2 trial results for elraglusib in treating metastatic pancreatic ductal adenocarcinoma...
Read more
Sivers Semiconductors has announced that it has joined the Digital Intermediate Frequency (IF) Interoperability (DIFI) Consortium, an independent space...
Read more
Aptamer Group plc has announced the successful adaptation of the Optimer-based test for Alzheimer’s disease into an Enzyme-Linked Immunosorbent...
Read more
PteroDynamics received a $7M contract to develop its new drone model, the XP5, for the US Navy. The 19-foot-wide...
Read more
NanoClear Technologies proudly announces that it has secured a worldwide exclusive license for Atomic Layer Polishing (ALP) from the...
Read more
Avvio Medical, Inc. announced the successful treatment of the first patients using its investigational Enhanced Lithotripsy System (ELS), a...
Read more
Clearsense announced today it has once again achieved Validated Data Stream status in the National Committee for Quality Assurance (NCQA)...
Read more
Pasadena Tech Firm GuRu Wireless to Showcase Infinite Flight Drone Technology at Military Conference
GuRu Wireless will be showcasing their infinite flight drone technology at SOF Week 2025 in Tampa, Florida. Read more here.
Read more
Actuate Therapeutics, Inc. (NASDAQ: ACTU) announced that Daniel Schmitt, President & Chief Executive Officer of Actuate will present at...
Read more
The future of drug development is changing, and Vivodyne is helping lead the way. With the FDA’s new push...
Read more